Propel 5020205
Propel 5020205 is a Class II device made by NuVasive, LLC, cleared under FDA 510(k) K103036 on 10 Jan 2011 and listed in FDA GUDID since 20 Dec 2018 (UDI-DI 00887517970435), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00887517970435 | Date20 Dec 2018 | StatusListed |
| United States | FDA 510(k)SESE | NumberK103036 | Date10 Jan 2011 | StatusActive |
Official records
- AccessGUDID record 00887517970435
- FDA 510(k) database K103036
Across registries
- FDA 510(k) K103036 decided 10 Jan 2011 Active
- FDA GUDID UDI-DI 00887517970435 listed 20 Dec 2018 Listed
Timeline
- Cleared FDA 510(k) K103036
- Listed FDA GUDID 00887517970435
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Propel
- Generic name
- Human-derived demineralized bone matrix implant
- Model / reference
- 5020205
- Primary DI / UDI-DI
- 00887517970435
- 510(k) Number
- FDA product code
- MQV, MBP
- GMDN term
- Human-derived demineralized bone matrix implant
- Device class
- Class II
- Regulation number
- 888.3045
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code MQV (FILLER, BONE VOID, CALCIUM COMPOUND).
- MCS Bone Graft by BIOVENTUS LLC
- BIOSORB RESORBABLE VOID FILLER by Sciences ET Bio Materiaux (Sbm)
- Mg OSTEOREVIVE™, Mg OSTEOCRETE™ by BONE SOLUTIONS, INC.
- Cerament Bone Void Filler by Bonesupport AB
- ORIGEN DBM WITH BIOACTIVE GLASS by Nanotherapeutics
- Actifuse Flow by Baxter Healthcare Corp
- SurFuse Gel, SurFuse Putty, ExFuse Gel, ExFuse Putty by Hans Biomed Corporation
- CarriGen PF by Etex Corp.
- CERAMENT BONE VOID FILLER, MODEL A0210 by Bonesupport AB
- Vitoss Bioactive (BA) Injectable by Orthovita, Inc.